AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT (MLD)Exclusive License Agreement • August 12th, 2025 • Passage BIO, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 12th, 2025 Company IndustryWHEREAS, Passage and Gemma entered into that certain Exclusive License Agreement (MLD), dated as of July 31, 2024 (the “Agreement”); and
AMENDMENT TO THE EXCLUSIVE LICENSE AGREEMENT (KRABBE)Exclusive License Agreement • August 12th, 2025 • Passage BIO, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledAugust 12th, 2025 Company IndustryWHEREAS, Passage and Gemma entered into that certain Exclusive License Agreement (Krabbe), dated as of July 31, 2024 (the “Agreement”); and